Search - tctmd.com

Displaying 681 - 700 of 1611

Sort: Relevancy | Date

Presentation TCT 2019

Why Onyx One?

Presenter: Ajay Kirtane

September 26, 2019

Presentation TCT 2019

Coronary Physiology Has Evolved: Where Is It Going?

Presenter: Ziad Ali

September 26, 2019

Presentation TCT 2019

Case #3: A Large Bore Venous Case With Complications

Presenter: David Daniels

September 26, 2019

News Conference News TCT 2019

Onyx ONE: Shorter DAPT Plus ZES Noninferior to Polymer-Free Stent in High-Bleeding-Risk Patients

L.A. McKeown

September 26, 2019

Presentation TCT 2019

Tackling Inflammation: Novel Targets

Presenter: Wolfgang Koenig

September 26, 2019

Presentation TCT 2019

LP(a): Not So Little Anymore

Presenter: Roberta Rossini

September 26, 2019

Presentation TCT 2019

Who is the High Bleeding Risk Patient?

Presenter: Daniel Simon

September 26, 2019

Presentation TCT 2019

Welcome

Presenter: Morton Kern

September 26, 2019

Presentation TCT 2019

Don’t Forget About Your HDL: The AEGIS Program

Presenter: C. Michael Gibson

September 26, 2019

Presentation TCT 2019

Case #2: Supported PCI in a Patient With Severe Peripheral Vascular Disease

Presenter: Ehrin Armstrong

September 26, 2019

Presentation TCT 2019

Role of PCSK9 Inhibitors Post-PCI and ACS

Presenter: Marc Bonaca

September 26, 2019

https://www.tctmd.com/news/ideal-lm-probes-short-dapt-and-bioabsorbable-polymer-stent-left-main-disease

News Conference News TCT 2019

IDEAL-LM Probes Short DAPT and a Bioabsorbable-Polymer Stent in Left Main Disease

Michael O'Riordan

September 26, 2019

Presentation TCT 2019

Loading Dose Statin Prior PCI: Is There a Role For It?

Presenter: Renato Lopes

September 26, 2019

Presentation TCT 2019

IDEAL-LM: A Randomized Trial of a Bioabsorbable Polymer DES With 4-Month DAPT vs. a Durable Polymer DES With 12-Month DAPT in Patients With Left Main Coronary Artery Disease

Presenter: Robert-Jan Van Geuns

September 26, 2019

Presentation TCT 2019

Case Resolution: How Did I Treat and What Happened?

Presenter: Amit Vora

September 26, 2019

Presentation TCT 2019

Onyx ONE: A Randomized Trial of a Durable-Polymer Drug-Eluting Stent vs. a Polymer-Free Drug-Coated Stent in Patients at High Risk of Bleeding Treated With 1-Month DAPT

Presenter: Stephan Windecker

September 26, 2019

Presentation TCT 2019

Transcaval Access: Technique and Problem Solving

Presenter: Toby Rogers

September 26, 2019

Presentation TCT 2019

The Approach to the High Bleeding Risk Patient: The Dos and the Don’ts!

Presenter: Bernard Chevalier

September 26, 2019

Presentation TCT 2019

Transcaval Access: Technique, Outcomes and Innovations

Presenter: Robert Lederman

September 26, 2019

Presentation TCT 2019

Long-Term Antithrombotic Therapy After PCI: How Do I Incorporate COMPASS Into My Practice?

Presenter: Robert Welsh

September 26, 2019

Advertisement

Why Onyx One?

Coronary Physiology Has Evolved: Where Is It Going?

Case #3: A Large Bore Venous Case With Complications

Onyx ONE: Shorter DAPT Plus ZES Noninferior to Polymer-Free Stent in High-Bleeding-Risk Patients

Tackling Inflammation: Novel Targets

LP(a): Not So Little Anymore

Who is the High Bleeding Risk Patient?

Welcome

Don’t Forget About Your HDL: The AEGIS Program

Case #2: Supported PCI in a Patient With Severe Peripheral Vascular Disease

Role of PCSK9 Inhibitors Post-PCI and ACS

IDEAL-LM Probes Short DAPT and a Bioabsorbable-Polymer Stent in Left Main Disease

Loading Dose Statin Prior PCI: Is There a Role For It?

IDEAL-LM: A Randomized Trial of a Bioabsorbable Polymer DES With 4-Month DAPT vs. a Durable Polymer DES With 12-Month DAPT in Patients With Left Main Coronary Artery Disease

Case Resolution: How Did I Treat and What Happened?

Onyx ONE: A Randomized Trial of a Durable-Polymer Drug-Eluting Stent vs. a Polymer-Free Drug-Coated Stent in Patients at High Risk of Bleeding Treated With 1-Month DAPT

Transcaval Access: Technique and Problem Solving

The Approach to the High Bleeding Risk Patient: The Dos and the Don’ts!

Transcaval Access: Technique, Outcomes and Innovations

Long-Term Antithrombotic Therapy After PCI: How Do I Incorporate COMPASS Into My Practice?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content